Last-Hope treatment offered for aggressive brain cancer patients
Disease control
NO_LONGER_AVAILABLE
This program provided gallium maltolate (GaM) capsules to adults with glioblastoma that had returned or stopped responding to standard treatments. Patients took one capsule daily by mouth at home for 28-day cycles. The goal was to offer a potential treatment option when no other …
Sponsor: Imaging Biometrics, LLC • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC